NDATOPICALCREAM
Approved
Mar 1980
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
3/8 — Basic
TOPICORT LP (desoximetasone) by Design Pharmaceuticals is corticosteroid hormone receptor agonists [moa]. Approved for plaque psoriasis in patients 18 years of age, older (), older and 1 more indications. First approved in 1980.
Drug data last refreshed 3d ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
TOPICORT LP is a topical corticosteroid cream containing desoximetasone, a corticosteroid hormone receptor agonist approved in 1980 for plaque psoriasis in adults 18 years and older. It works by binding to glucocorticoid receptors to reduce inflammation and immune-mediated skin responses characteristic of psoriasis.
LOE Approaching
As an older corticosteroid approaching loss of exclusivity, the brand team is likely focused on line extension strategies and defending market position against generic erosion.
Mechanism of Action
Corticosteroid Hormone Receptor Agonists
Indications (4)
Worked on TOPICORT LP at Design Pharmaceuticals? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.